From: Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma
Pathology
No. of patients
Types
NHL
15 (45.5%)
HL
17 (51.5%)
GALT
1 (3.0%)
Subtypes
NHL-DLBCL
12 (36.4%)
NHL-TCL
1 (3%)
NHL-F
2 (6%)
HL-NS
10 (30.3%)
HL-MC
5 (15.2%)
HL-LP